The history of patients with idiopathic pulmonary fibrosis (IPF) 
The technical aspects regarding adenovirus detection nificantly associated with idiopathic pulmonary fibrosis (IPF). in the study by Kuwano et al, 1 including the negative Far from finding an association of E1A DNA with E1A polymerase chain reaction (PCR) controls and the IPF, the authors of the introductory article found the nested PCR for E1A DNA which was shown to be some incidence in both treated and untreated cases was sig-100 times more sensitive than conventional PCR, seem nificantly less than in previous normal controls or quite satisfactory. Unfortunately, normal control lung patients with COPD. Since small transbronchial biopsy tissue was not included in this study.
specimens were used in the IPF studies, sampling might However, Matsuse et al 2 had previously demonstrated account for part of the low yield. Alternatively, the E1A DNA in 87% of paraffin embedded lung samples authors suggest that, since the E1A region of adenovirus obtained from patients undergoing resection for lung is responsible for sensitising infected cells to cytolysis cancer. They also found E1A DNA in 90% of tissue by tumour necrosis factor (TNF), natural killer (NK) samples from smokers with COPD compared with 44% cells and activated macrophages, this might lead to the of smokers without COPD. In view of the frequency of elimination of virus by the host's immune response. The detection of E1A DNA on tissue from normal subjects finding of a somewhat higher prevalence of virus in and those with COPD, it is difficult to understand why corticosteroid treated cases (but still less than in normal the authors postulated that, using the same techniques, controls) where immune responses might be reduced, they might be able to demonstrate adenovirus sigcould support such an explanation. It is conceivable that an active adenovirus infection might be an initiating event but that the consequential inflammatory response
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Turner-Warwick response in the lung. If patients could be studied shortly tures of "pulmonary fibrosis", they often show features which distinguish them from CFA including asbestos, after their virus-like episode, more evidence might be obtained. This, however, is likely to be very difficult silica, coal, graphite, hard metal, avian proteins and pharmaceutical drugs. 11 It is therefore necessary to exbecause viral-like illnesses are very common but very few patients subsequently develop IPF. The lack of clude all possible "external causes" before making a diagnosis of CFA. However, in clinical practice the response to the antiviral agent ribavarin in advanced cases of IPF 3 suggests that viral agents are not conapproach to such exclusions has varied. Some clinicians will exclude cases where there is a potential external tributing to the progression of late stage disease, irrespective of whether or not they are involved as an causal factor suggested by a substantial occupational history and especially when the lung biopsy or bronchoinitiating agent. alveolar lavage sample shows a heavy burden of dust or mineral, even when the putative agent is not currently formally accepted as a cause of pneumoconiosis for Implication of other viruses This topic has recently been reviewed in considerable compensation purposes. Other clinicians will only exclude those exposed to agents accepted as established detail by Egan et al 4 and one or two interesting pointers will be outlined briefly here. There has recently been causes of pneumoconiosis, classifying all other cases as "cryptogenic". Either approach is justifiable, depending considerable interest in Epstein-Barr virus (EBV). Its implication in IPF was first suggested in 1984 5 when on the purpose of the studies. However, when the latter approach is taken, and in view of the wide range of Vergnon et al found raised levels of immunoglobulins G and A to viral capsid antigen (VCA). A more recent agents associated with the development of pulmonary fibrosis, it is not surprising that systematic searches study 6 explored the possibility of identifying replicating EBV in tissue samples and demonstrated positive stainfor occupations with exposure to various dusts reveals patients provisionally diagnosed as having "cryptogenic" ing using immunohistochemical techniques for VCA and the membrane antigen gp340/220. Positive staining fibrosing alveolitis. In a preliminary case-control study Scott et al 12 rewas found in 14 of 20 patients with IPF but in only two of 21 control samples taken from lung tissue removed at ported evidence of an association between IPF and wood and metal dusts. This work was extended 13 in a the time of resection of lung cancers.
The same authors also studied the presence of EBV further case control study in which 218 patients diagnosed as having CFA were compared with 569 controls DNA using nested PCR and obtained positive results in 11 of 20 cases of IPF compared with one of eight matched for age and sex obtained through GP registers. Their life time occupational histories were reassessed normal lungs and one of eight cases of sarcoidosis. 7 However, these findings were not confirmed by another by questionnaire and telephone interview. After adjusting for smoking there was a significantly increased group 8 who studied 12 patients with CFA, two with associated systemic sclerosis, three with diffuse alveolar relative risk for exposure to a wide range of metals as well as a wide variety of woods. A significant increased damage, and one each with desquamative interstitial pneumonitis (DIP), extrinsic allergic alveolitis (EAA), relative risk to specific metals was only found for lead, brass and steel; pine was the only specific wood identified. and idiopathic haemosiderosis. EBV DNA was sought using PCR amplification and EBV RNA using in situ
In both groups the exposure history was substantial, extending over years. While the risk increased with hybridisation (ISH) and immunohistochemistry to identify three well defined EBV antigens (VCA, BZ-1, duration in years of exposure to metals, oddly the risk decreased with length of exposure to wood dust. 14 The and CS1-4). While EBV antigen staining was positive in a patchy distribution in the majority of samples and study concluded that the combined fraction of both wood and metal exposure in this series might account throughout the different types of lung diseases studied, EBV DNA was identified in small amounts on one for about 20% of cases of CFA (10-13% of cases exposed to metal dusts and 5-10% of those exposed to occasion in only three samples (two CFA and one foregut cyst) but was not identified on repeat sampling. wood dusts). These results are supported by a case control study on necropsy material from 1137 cases in The resolution of these conflicting studies might be helped by exchange of further samples, by further work whom IPF was significantly related to those exposed to metal and wood as well as laundry workers, barbers, to standardise and optimise the difficult techniques employed, and by studying larger groups of well defined beauticians and painters. 15 In a further case-control study by the same authors in which 86 living patients patients.
Other viruses have also been suggested. Ueda et al 9 with IPF were compared with hospital controls there was a significant relationship with those with a history found antibodies to hepatitis C (HVC), an RNA virus, in 28% of patients with IPF but this may have been due of working with metal and in mines. Another recent study in which 248 patients with IPF were compared to a high number of false positive results and the high background rate of HVC infection. Currently there seems with age, sex and geographically matched controls found a significant association in those involved with farming, to be little evidence of a specific relationship with CFA.
The possibility remains that one or more virus inhairdressing, exposure to metal dust, raising birds, stone cutting and exposure to animal and vegetable dusts. 16 fections may initiate inflammation which may lead on to a fibrosing process, either as a result of a T cell As suggested above, because of the substantial exposures likely to have been recorded in the routine mediated inflammatory response or, alternatively, by transforming smooth muscle cells or fibroblasts resulting clinical history, some clinicians might not have included some of these cases under the heading "cryptogenic" in a phenotype which expresses genes involved in the synthesis of matrix proteins or profibrotic mediators. 10 but rather flagged them as possibly associated with dust exposure, especially if the biopsy or lavage specimen was heavily laden with dusts. Furthermore, where macrophages are heavily laden with dust particles or Occupational "causes" of patients previously labelled as CFA where interstitial deposits are found, many pathologists would proceed to birefringent studies, electron microWhile many minerals and dusts can be associated with the general clinical, radiographic, and pathological feascopy, or even studies using analytical microprobes. For example, a study by Johnson et al 17 identified particles adult IPF. 10 23 24 The genetic basis for this group may therefore be different. Of particular interest is the obwhich were related to known exposures, superimposed on a background of other particles relating to smoking servation in three families with familial IPF where nonaffected members also had increases in the levels of (kaolinite and mica) and to the general environment (silicon, titanium and iron). The study was particularly various inflammatory components in BAL fluid samples including neutrophils, activated macrophages, and helpful when light microscopy indicated retention of dust in patients with no known history of exposure. In fibroblast growth factors. 25 The genetic factor or factors determining these changes has not yet been identified. this context it would be interesting to know whether, in the multicentre case control study discussed above, 13 In fibrosing lung disease due to a variety of known occupational exposures such as beryllium and asbestos the substantial exposure identified on the systematic questionnaire had also been recorded in the initial clinnot all individuals with apparently similar exposure develop the disease, suggesting a genetic or non-genetic ical case history. It would also be interesting to know how often biopsy or lavage was performed, whether predisposition. In searching for "causes" it should not be forgotten that, even when there is a clearly defined these samples showed a heavy dust burden, and whether this had triggered the pathologists to ask for further cause supported by experimental challenge studies showing a "linear" dose-response curve measuring indetails. It would be particularly interesting if tissue or lavage material was available which failed to find jury, this demonstrates two things rather than one. On the one hand it indicates the strong influence of the inorganic material or other particles in these lungs on light microscopy. A case has recently been reported of agent on the development of the disease under study but, in addition, it also demonstrates that at points a carpenter with clinical CFA who had been exposed to fibreglass in whom fibreglass was only identified by along the dose-response curve subjects receiving the same controlled dose may or may not develop the disease, analytical electron microscopic examination and was not identified on routine light microscopy or by bidepending on variations in genetic as well as non-genetic factors. For example, there is now considerable evidence refringence. 18 One of the problems with the current trend of making that genetic host factors play a dominant role in susceptibility at low doses of exposure but that injury due the clinical diagnosis of CFA supported by CT scans but without supporting pathological material or to the external agent predominates at high doses. 26 Even in experimental studies using inbred strains of animals bronchoalveolar lavage (BAL) samples is that the suspicion of such initiating agents may be overlooked.
the intrinsic susceptibility of the species and inherent non-genetic influences will both influence the doseHowever, notwithstanding these specific points, there seems to be increasing evidence that a wide range of response relationship to external agents.
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The major histocompatibility complex (MHC) locexternal dusts including some metals and wood not yet officially accepted as causing pneumoconiosis may ated on chromosome 6, encoding HLA molecules on the surface of presenting cells, is functionally associated contribute in some way -either as an initiating agent or as a contributing factor -in a few cases of pulmonary with T cell receptor (TcR) recognising foreign proteins. This is the driving force of the immune response and fibrosis previously categorised as being of "unascertained" cause. This fraction will be smaller in series results in T cell activation, cytokine production, and antibody formation. 23 24 Although reports on the asof patients where some would have been excluded on the basis of their possible dust exposure. It is also likely sociation of MHC and CFA remain conflicting, 28 29 results from studies on fibrosing alveolitis in systemic to be smaller in populations which in general are less exposed to external dusts of these types. sclerosis (FASSc) are much clearer. For example, Briggs et al 30 have shown HLA-DR3/DR52a alleles and/or The identification of exposure to a very wide variety of metals, woods and other dusty materials with a higher the anti-Scl-70 autoantibody to be risk factors for the development of FASSc. Another study identified the risk being associated with only very few specific materials, and the fact that these exposures account for only a TGF gene -a growth factor with many functions including fibrogenesis polymorphism (A25P) -to be small number of cases of CFA, perhaps favours the suggestion that these dusts may act in a non-specific way significantly associated with FASSc but not CFA. 31 The genes within the MHC region are highly polyas contributing factors in genetically or non-genetically predisposed individuals, rather than acting as specific morphic and are associated with autoimmune disease. The clinical picture of CFA is well recognised in asinitiating agents.
Many reports have observed a high frequency of sociation with many cases of systemic sclerosis and some, albeit less commonly, with rheumatoid arthritis smoking amongst patients with CFA; 74% of patients in an early large survey were smokers or ex-smokers 19 and systemic lupus erythematosus. Furthermore, there is an increased incidence of non-organ specific autoand smoking as a risk factor has been confirmed more recently. 20 The response to corticosteroids also seems antibodies (rheumatoid factor and antinuclear antibody) in patients with "lone" CFA. 32 A very recent study using to be less good in smokers, 21 but whether or not this is another example of a non-specific dust risk factor or new molecular techniques has demonstrated specific autoantibodies to type II pneumocytes in CFA.
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whether the components of cigarette smoke, perhaps by recruiting neutrophils to the lungs, 22 contribute more Evidence for the implication of 1 -antitrypsin, the potent inhibitor of neutrophil protease in the despecifically by promoting inflammation initiated by some other agent remains unproven.
velopment of fibrosis, in rheumatoid arthritis is conflicting. Geddes et al 34 demonstrated that possession of the non-MM phenotype of the Pi loci coding for 1 -antitrypsin, especially MZ, was associated with the dePossible implication of genetic factors modulating immunological responses, velopment of pulmonary fibrosis in patients with rheumatoid arthritis. This finding was not, however, confirmed inflammation, and fibrogenesis Several facts suggest the implication of genetic factors in by Steers et al. 35 Larger numbers need to be studied to resolve this question. the development of fibrosing lung disease. For example, familial CFA is well recognised but many of these cases
The field of genetics in fibrosing lung disease is now rapidly developing and is of great potential importance. present in infancy and in this respect are distinct from group.bmj.com on April 8, 2017 -Published by http://thorax.bmj.com/ Downloaded from It should help our understanding of pathogenesis, inAll of these problems are very relevant to the recent reports attempting to define some of the possible inicluding immunological and host inflammatory responses in fibrosing lung disease, the susceptibility to tiating factors in CFA. fibrosis, the rate of progression of fibrosis, and the prognosis. There have been several useful reviews covering the current knowledge in this field.
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Clarification of terminology in relation to known and unknown causal factors The general term "interstitial pulmonary fibrosis" based on pathological features characterises a lung tissue reImportant general considerations in attempting to find new "causes" sponse to a range of known external agents as well as those with an unidentified cause, resulting in injury to In order to evaluate the recent attempts to identify causal agents in cryptogenic fibrosing alveolitis, it may any part of the lung which heals with a tendency towards fibrosis rather than resolution. If the definition is narbe useful to restate some of the inherent problems when working in this difficult field. In doing so, some ideas rowed to specify the characteristic of lower zone predominance, the range of initiating agents is reduced but on possible new approaches will be made.
The aetiological factors in any disorder defined in still includes asbestos, coal dust (typically those in which "p" appearances are evident on the radiograph (ILO clinicopathological terms include the initiating agent(s) -for brevity referred to in this article as "causes" -classification)), graphite, 37 some unusual cases of silica, 38 and hard metal. 39 This list is not yet complete and new contributing factor(s), and the consequential host cellular and humoral responses. The interaction between agents are continually being suggested. 13 18 However, and only for the time being, there are groups these three sets of factors is complex. When initiating agents are difficult to find it is understandable but often of patients with many clinical features in common which show a similar fibrosing histological pattern in which misleading to attribute a "causal" role to a factor which is more properly a contributing factor or part of the no cause has yet been identified; these were initially labelled as IPF. Although meaning "unknown", imhost response.
It is not uncommon for a disorder defined in clinicoplying that with further knowledge more causes would be identified, the term has sometimes been used to pathological terms to have more than one initiating agent. It is also well recognised that distinctive conimply that IPF represents a "disease entity" where there is no initiating agent. In order to stress the importance ditions, often with a known cause and well characterised host responses, progress to a final common path of of recognising our current incomplete state of knowledge, the term "cryptogenic" ("hidden") was inpathological changes which determine a common set of clinical features at this late stage. When in clinical troduced to stress the likelihood of identifying more causes in the future, hopefully and eventually leading practice patients only present at a late stage, it is understandable to regard this as a single disease entity to the elimination of the term. The qualifying adjective "fibrosing" was introduced to describe more accurately albeit with one or more "causes".
When, as is common in medicine, there is no identhe histological features which almost always included an inflammatory response of varying degree as well as tifiable cause, a disorder has to be defined in descriptive terms. Where the characterising features are present in established fibrosis.
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Further difficulties have arisen as more histological all the patients, which unfortunately is rarely the case, research into causes and pathogenesis of such a homovariants have been identified in patients presenting with the same -albeit crudely described -clinical, physiogeneous group can be built on a firm base. However, when the definition is based on a cluster of clinicological, and radiographic features. Although it is not yet complete, there seems to be increasing evidence that pathological features which distinguishes the group of patients from others, but in which individuals do not histological variants such as desquamative interstitial pneumonitis (DIP), 41 giant cell pneumonia (GIP) which necessarily have all the features, research into causation of these heterogeneous groups of patients becomes much is now recognised as frequently being associated with hard metal exposure, 41 and even lymphocytic interstitial more difficult. When, for example, there is a range of histological patterns in a clinically defined group, do pneumonia (LIP) which is often associated with systemic lymphoproliferative disease 42 and some viral inthese represent different stages of the same condition, do they indicate subgroups with different initiating facfections, 43 are distinctive conditions although they may progress in at least some patients to an advanced fitors, or does the variation in histology reflect the influence of contributing factors or host responses (to a brosing stage, histologically similar to usual interstitial pneumonia (UIP) as described by Liebow. 44 single or several causes)? In order to dissect out definitively the role of all these Recently a new approach relating to pathogenesis has been suggested. 45 Cases in which the histological variables in search of causation, large numbers of cases are necessary. However, when the disorder is relatively appearances, which may be cellular, mixed or fibrotic, appear to be distributed evenly and uniformly across rare answers are very difficult to obtain unless some very strong and clearcut evidence emerges. Further, the whole of the biopsy specimen led the authors to suggest that the appearance reflected a single initial when attempts are made to increase numbers by undertaking multicentre studies on these heterogeneously insult in time. They proposed the term "non-specific interstitial pneumonia" (NSIP) to distinguish these defined groups, there is no certainty that the variables are evenly distributed between the different centres. For cases from UIP characterised by a patchy mixing of cellular, fibrotic and destructive features which, they example, environmental and occupational factors may vary considerably between rural and urban centres or suggested, reflected repeated injury extending over periods of time. The practical value of this approach is the referrals to some centres may have a bias towards late stage disease. Prospective studies with tightly agreed that cases showing features of NSIP seem to have a better survival and respond more readily to inclusion and exclusion criteria and with equally tight clinical and laboratory protocols should help, but these treatment. 45 46 Earlier studies have shown that CFA with a more "cellular" histological pattern has a better have encountered many practical difficulties even when attempted.
prognosis and responds better to treatment. 47 48 It is now group.bmj.com on April 8, 2017 -Published by http://thorax.bmj.com/ Downloaded from important to see whether the criteria previously used to ""  In an attempt to study the earliest changes, electron define a "cellular" pattern correspond to those of nonfibrotic NSIP. It seems that the fundamental factor microscopy was used to study the ultrastructure of the most normal parts of the lung in biopsy specimens from determining a better prognosis and response to treatment may depend more on whether the alveolar arsubjects with CFA. 54 This indicated damage to both pulmonary capillary endothelium and pulmonary epichitectural framework is substantially intact, irrespective of the precise type of histological variant which has been thelial cells in the absence of inflammatory cell infiltration. Furthermore, the studies suggested that this classified in so many different ways. On the other hand, where the alveolar units are destroyed ("honeyearly destruction of epithelial cells was followed by an intra-alveolar exudate which became organised and combing") then prognosis is less good. Adequate sized biopsy specimens are essential to establish this and CT incorporated into the alveolar walls with repair by type II cells growing over it. These observations throw a scans are especially helpful.
In clinical practice the value of obtaining histological rather different light on early pathogenesis from the more conventional emphasis on the inflammatory cell material in presumed CFA is twofold. Firstly, it can exclude a range of other pathologies which can mimic response which may be a later event. If, as seems probable, epithelial and endothelial damage represents fibrosing alveolitis and secondly, as discussed above, it can indicate the likely prognosis and responsiveness the earliest changes in CFA, then it is important to focus on the pulmonary endothelium and epithelium. to treatment. If the latter fundamentally depends on whether the lung architecture is intact or destroyed, then high resolution computerised tomography (HRCT) should provide a non-invasive way of es-  Following this line of argument, serial non-invasive tablishing this. Several studies have now demonstrated its value in groups of patients.
49-51 However, in view of studies of lung permeability (reflecting epithelial damage in particular) have been undertaken and have shown the very serious prognosis in most cases of CFA and the difficulties and risks of treatment, a good case that restoration of normal permeability with treatment is associated with a clinical response to treatment and remains for obtaining both histological material and radiographic evidence to exclude other conditions until continued increased permeability is associated with deterioration. 55 the reliability of CT scanning in all individual patients has been proved beyond doubt.
   
Most reports agree that the median duration of disease Some special features of CFA yet to be explained and requiring more research from presentation to death is rapid over about five years. This dramatic progression of the inflammatory and When attempting to identify new causes of CFA it is worth emphasising some of the special features which, fibrotic response with increasing architectural destruction of alveolar units and a poor response to treatalthough not present in every case, distinguish this group of patients from other types of pulmonary fibrosis. These ment in most cases is one of the most characteristic features of CFA that needs an explanation. The potential features require explanation and are important because they may stimulate ideas for new lines of research on importance of contributing factors such as inhaled environmental dusts and cigarette smoke, and genetic the role of various aetiological factors.
factors especially relating to control of host responses, are now under intensive investigation.    The disease is predominantly located in the peripheral parts of the lower zones. The distribution is not seg-    "  " The debate continues as to whether the fibrosing almental and does not seem to follow bronchial, vascular, or lymphatic pathways. This distribution is also found veolitis found in association with a variety of so-called collagen vascular diseases -especially systemic sclerosis, in some cases related to inhaled particles, especially asbestos. In cases with minimal involvement -which rheumatoid arthritis, and systemic lupus erythematosus (SLE) -should be regarded as an entity which is may or may not be the same as early disease -HRCT scanning has shown that the changes are first seen under distinct from lone fibrosing alveolitis. The arguments are somewhat spurious. On the one hand there is conthe parietal pleural surface of the lung and then progress to involve more central areas. This requires explanation.
siderable evidence that a large number of clinical, physiological, radiographic, and pathological features are virtually identical and are shared by both conditions but, on the other hand, there are a number of features   Many different reports agree that, in contrast to many that are quite distinctive. For example, a formal study comparing the histological features of FASSc with lone other types of pulmonary fibrosis, 40-50% of cases have finger clubbing. 19 The explanation for finger clubbing is fibrosing alveolitis on light microscopical study found them indistinguishable. 56 However, systematic studies unknown but its association with proliferation of the bronchial vasculature described more than 30 years ago 52 have now confirmed that the rate of progression in FASSc is much slower. 57 58 and, as far as I am aware, not yet confirmed by others, indicates that new studies on this subgroup using new Non-organ specific autoantibodies including antinuclear antibody and rheumatoid factor are found in knowledge and techniques on angiogenesis might give new insight into the progression of fibrosis and may even both fibrosing alveolitis associated with collagen vascular diseases (FA-CV) and lone fibrosing alveolitis, albeit open new lines of treatment. A recent study using extracts from lung biopsy specimens suggests that there is an with quantitative differences. 59 However, antibodies to a wide range of other cell component antigens are clearly imbalance between higher than normal levels of interleukin 8 (IL-8) and reduced levels of interferon (IFN )-indistinctive both in FA-SLE and FASSc. As noted above, recent studies have shown distinctive genetic aberraducible protein (IP-10) in CFA favouring angiogenesis. tions. 30 Thus a more practical and constructive approach
